Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Wuzhou Pharmaceutical is a China-based pharmaceutical company specializing in the development and production of chemical drugs and traditional Chinese medicines (TCM). Founded in the late 1990s and subsequently acquired by Fosun Pharma, the company operates as a key manufacturing subsidiary within the Fosun Group. Its product portfolio includes a variety of oral formulations and active pharmaceutical ingredients focused on cardiovascular health, gastroenterology, and anti-infectives. The company maintains GMP-certified facilities in Shanghai and is recognized for its integration of modern pharmaceutical standards with traditional medicinal practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Wuzhou Pharmaceutical.